Daniel Donovan - 29 Jun 2023 Form 3 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Director
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Issuer symbol
INTS
Transactions as of
29 Jun 2023
Net transactions value
$0
Form type
3
Filing time
29 Jun 2023, 19:55:35 UTC
Previous filing
29 Mar 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTS Stock Option (right to buy Common Stock) 29 Jun 2023 Common Stock 25,000 $9.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is vested and exercisable with regard to 6,250 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued service as a director of Intensity Therapeutics, Inc., in three equal annual installments, beginning December 13, 2023.

Remarks:

Exhibit 24 - Power of Attorney